Amphastar Pharmaceuticals, Inc. (AMPH) Shareholders’ equity 2016–2025
Amphastar Pharmaceuticals, Inc. (AMPH) shareholders’ equity at each fiscal year-end, per SEC filings.
$788.8MFY2025 · since FY2016: $329.3M → $788.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $788.8M | +7.7% |
| FY2024 | $732.3M | +14.5% |
| FY2023 | $639.4M | +21.0% |
| FY2022 | $528.7M | +18.7% |
| FY2021 | $445.5M | +10.7% |
| FY2020 | $402.3M | +5.5% |
| FY2019 | $381.4M | +14.7% |
| FY2018 | $332.4M | -0.4% |
| FY2017 | $333.7M | +1.4% |
| FY2016 | $329.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice